SEC Tracker
Get the app

Connect Biopharma Holdings CNTB

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical

Form
8-K
Filed
Period
Importance
Notable
Document
8-K
Exhibit 99.1
Press release
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Connect Biopharma Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CervoMed CRVO public float $40M, Jun 30, 2025
  2. Actuate Therapeutics ACTU public float $42M, Jun 30, 2025
  3. Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
  4. Lite Strategy LITS public float $43M, Dec 31, 2025
  5. BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026